{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:22:09Z","timestamp":1795026129132,"version":"4.10.2"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To evaluate whether pelvic floor muscle training using a motion-based digital intravaginal device is more effective than home pelvic floor muscle training for treatment of stress or stress-predominant mixed urinary incontinence (UI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>In a remote, virtually executed 8-week prospective randomized controlled superiority trial, women with stress or stress-predominant mixed UI were randomized to pelvic floor muscle training using a motion-based digital therapeutic device or a home training program using written and narrated instructions. Primary outcomes were change in UDI-6 (Urogenital Distress Inventory, Short Form) score and stress urinary incontinence (SUI) episodes on a 3-day bladder diary. A sample size of 139 per group (n=278) was planned to meet the power analysis requirements for the UDI-6 score (n=278) and the bladder diary (n=78). Prespecified secondary outcomes included quality-of-life surveys and adherence reporting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      From September 2020 to March 2021, 5,353 participants were screened, and 363 were randomized: 182 in the intervention and 181 in the control group. There were no baseline clinicodemographic differences between groups. The mean change in UDI-6 score was significantly greater for the intervention group compared with the control group (18.8 vs 14.7,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.01). The median (interquartile range) number of SUI episodes on the 3-day bladder diary was significantly reduced from 5 (3\u20138) and 5 (3\u20138) episodes to 1 (0\u20133) and 2 (1\u20134) (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.005) in the intervention group compared with control group, respectively. A significantly greater number of participants in the intervention group than in the control group reported they were \u201cmuch improved\u201d or \u201cvery much improved\u201d on the PGI-I (Patient Global Impression of Improvement) (63\/143 [44.1% vs 45\/156 [28.8%], odds ratio 1.94, 95% CI 1.21\u20133.15). There were no device-related severe adverse events.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>In this all-remote, virtually conducted trial, pelvic floor muscle training guided by a motion-based digital therapeutic device resulted in significantly improved UI symptoms and reduction of UI episodes compared with a home training program.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CLINICAL TRIAL REGISTRATION:<\/jats:title>\n                    <jats:p>ClinicalTrials.gov, NCT04508153.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>FUNDING SOURCE:<\/jats:title>\n                    <jats:p>Renovia Inc.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000004725","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T17:08:34Z","timestamp":1646932114000},"page":"606-615","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":32,"title":["Digital Therapeutic Device for Urinary Incontinence"],"prefix":"10.1097","volume":"139","author":[{"given":"Milena M.","family":"Weinstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gena","family":"Dunivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelani M.","family":"Guaderrama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly E.","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,3,10]]},"reference":[{"key":"R1-20260916","doi-asserted-by":"crossref","first-page":"166.e1","DOI":"10.1016\/j.ajog.2021.03.016","article-title":"Prevalence and trends in urinary incontinence among women in the United States 2005-2018","volume":"225","author":"Abufaraj","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"R2-20260916","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1097\/AOG.0b013e3181c2ce96","article-title":"Forecasting the prevalence of pelvic floor disorders in U.S. women: 2010 to 2050","volume":"114","author":"Wu","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R3-20260916","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00192-018-3596-4","article-title":"Does transition of urinary incontinence from one subtype to another represent progression of the disease?","volume":"29","author":"Minassian","year":"2018","journal-title":"Int Urogynecol J"},{"key":"R4-20260916","doi-asserted-by":"crossref","first-page":"502.e1","DOI":"10.1016\/j.ajog.2018.01.045","article-title":"A prospective study of the natural history of urinary incontinence in women","volume":"218","author":"Hagan","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"R6-20260916","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/GME.0000000000000943","article-title":"Factors associated with reasons incontinent midlife women report for not seeking urinary incontinence treatment over 9 years across the menopausal transition","volume":"25","author":"Waetjen","year":"2018","journal-title":"Menopause"},{"key":"R7-20260916","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11934-015-0572-0","article-title":"Pelvic floor muscle training: underutilization in the USA","volume":"17","author":"Lamin","year":"2016","journal-title":"Curr Urol Rep"},{"key":"R8-20260916","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/nau.24256","article-title":"Implementing pelvic floor muscle training in women's childbearing years: a critical interpretive synthesis of individual, professional, and service issues","volume":"39","author":"Salmon","year":"2020","journal-title":"Neurourol Urodyn"},{"key":"R9-20260916","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/nau.22771","article-title":"Pelvic floor muscle training adherence \u201cmodifiers\u201d: a review of primary qualitative studies - 2011 ICS state-of-the-science seminar research paper III of IV","volume":"34","author":"Hay-Smith","year":"2015","journal-title":"Neurourol Urodyn"},{"key":"R11-20260916","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s00192-019-04012-w","article-title":"Mobile technologies for the conservative self-management of urinary incontinence: a systematic scoping review","volume":"31","author":"Bernard","year":"2020","journal-title":"Int Urogynecol J"},{"key":"R12-20260916","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/cpt.1036","article-title":"Digital therapeutics: an integral component of digital innovation in drug development","volume":"104","author":"Sverdlov","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"R13-20260916","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1002\/nau.24097","article-title":"Evaluation of an accelerometer\u2010based digital health system for the treatment of female urinary incontinence: a pilot study","volume":"38","author":"Rosenblatt","year":"2019","journal-title":"Neurourol Urodyn"},{"key":"R14-20260916","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/SPV.0000000000001052","article-title":"Multicenter randomized controlled trial of pelvic floor muscle training with a motion-based digital therapeutic device versus pelvic floor muscle training alone for treatment of stress-predominant urinary incontinence","volume":"28","author":"Weinstein","year":"2021","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"R15-20260916","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00192-020-04314-4","article-title":"A guide for urogynecologic patient care utilizing telemedicine during the COVID-19 pandemic: review of existing evidence","volume":"31","author":"Grimes","year":"2020","journal-title":"Int Urogynecol J"},{"key":"R16-20260916","doi-asserted-by":"crossref","first-page":"106406","DOI":"10.1016\/j.cct.2021.106406","article-title":"Randomized trial comparing efficacy of pelvic floor muscle training with a digital therapeutic motion-based device to standard pelvic floor exercises for treatment of stress urinary incontinence (SUV trial): an all-virtual trial design","volume":"105","author":"Weinstein","year":"2021","journal-title":"Contemp Clin Trials"},{"key":"R17-20260916","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0022-5347(17)45194-9","article-title":"Prevalence of urinary incontinence and other urological symptoms in the noninstitutionalized elderly","volume":"136","author":"Diokno","year":"1986","journal-title":"J Urol"},{"key":"R19-20260916","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ajog.2004.12.025","article-title":"Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7)","volume":"193","author":"Barber","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"R20-20260916","doi-asserted-by":"crossref","first-page":"580. e1","DOI":"10.1016\/j.ajog.2009.02.007","article-title":"The minimum important differences for the urinary scales of the Pelvic Floor Distress Inventory and Pelvic Floor Impact Questionnaire","volume":"200","author":"Barber","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"R21-20260916","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1067\/mob.2001.118659","article-title":"Psychometric evaluation of 2 comprehensive condition-specific quality of life instruments for women with pelvic floor disorders","volume":"185","author":"Barber","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"R22-20260916","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/nau.22833","article-title":"Predictive modeling and threshold scores for care seeking among women with urinary incontinence: the short forms of the Pelvic Floor Distress Inventory and Urogenital Distress Inventory","volume":"35","author":"Gafni-Kane","year":"2016","journal-title":"Neurourol Urodyn"},{"key":"R23-20260916","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1067\/mob.2003.379","article-title":"Validation of two global impression questionnaires for incontinence","volume":"189","author":"Yalcin","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R24-20260916","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.tjog.2021.05.015","article-title":"Urogynecological survey in a group of Italian women treated for overactive bladder: symptoms and quality of life analysis during the Covid-19 period","volume":"60","author":"Schiavi","year":"2021","journal-title":"Taiwan J Obstet Gynecol"},{"key":"R25-20260916","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jsxm.2020.06.006","article-title":"Love in the time of COVID-19: sexual function and quality of life analysis during the social distancing measures in a group of Italian reproductive-age women","volume":"17","author":"Schiavi","year":"2020","journal-title":"J Sex Med"},{"key":"R26-20260916","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jphys.2015.08.005","article-title":"Strategies to enhance self-efficacy and adherence to home-based pelvic floor muscle exercises did not improve adherence in women with urinary incontinence: a randomised trial","volume":"61","author":"Sacomori","year":"2015","journal-title":"J Physiother"},{"key":"R27-20260916","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.cct.2014.04.009","article-title":"Web-based trial to evaluate the efficacy and safety of tolterodine ER 4 mg in participants with overactive bladder: REMOTE trial","volume":"38","author":"Orri","year":"2014","journal-title":"Contemp Clin Trials"},{"key":"R28-20260916","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.ajog.2006.02.050","article-title":"Can we screen for pelvic organ prolapse without a physical examination in epidemiologic studies?","volume":"195","author":"Barber","year":"2006","journal-title":"Am J Obstet Gynecol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000004725","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:01:54Z","timestamp":1789556514000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000004725"}},"subtitle":["A Randomized Controlled Trial"],"short-title":[],"issued":{"date-parts":[[2022,3,10]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000004725","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,10]]},"assertion":[{"value":"2021-10-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}